Showing 91 - 100 of 283
Persistent link: https://www.econbiz.de/10012290777
Persistent link: https://www.econbiz.de/10012268798
Persistent link: https://www.econbiz.de/10011585534
Persistent link: https://www.econbiz.de/10011665383
Persistent link: https://www.econbiz.de/10012005736
Persistent link: https://www.econbiz.de/10011745278
Persistent link: https://www.econbiz.de/10011745302
Persistent link: https://www.econbiz.de/10011708842
Persistent link: https://www.econbiz.de/10011801801
The National Institute for Health and Care Excellence (NICE) invited the manufacturer of ruxolitinib (Novartis) to submit clinical and cost-effectiveness evidence for ruxolitinib within its licensed indication (the treatment of disease-related splenomegaly or symptoms in adult patients with...
Persistent link: https://www.econbiz.de/10011001556